Ajanta Pharma

Ajanta Pharma is a specialty pharmaceutical formulation company with a diversified business in Branded Generics, US Generics, and institutional sales across India, Asia, and Africa. The company is committed to creating a long-term sustainable and scalable business, an effort that is now yielding encouraging results across its operational markets. Its strategy focuses on strengthening its business by prioritising chronic therapies, which ensures consistent and sustained growth for years to come. This growth is backed by a strong Research and Development team of over 850 scientists who focus on creating complex and difficult-to-make products. A key part of its business model is launching innovative products, with about 50% of its portfolio in various markets being first-to-market introductions. As a result, its Branded Generics segment achieved its highest-ever contribution, providing 74% of the company's total revenue in fiscal year 2025.;